The company expired its plan on April 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.85 CNY | -1.39% | +0.54% | -1.92% |
Apr. 29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.92% | 2.46B | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.